14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Insulin Sensitivity in 3 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skepner, JE | 1 |
| Shelly, LD | 1 |
| Ji, C | 1 |
| Reidich, B | 1 |
| Luo, Y | 1 |
| Chadderdon, SM | 1 |
| Belcik, JT | 1 |
| Smith, E | 1 |
| Pranger, L | 1 |
| Kievit, P | 1 |
| Grove, KL | 1 |
| Lindner, JR | 1 |
| Miller, AW | 1 |
| Dimitropoulou, C | 1 |
| Han, G | 1 |
| White, RE | 1 |
| Busija, DW | 1 |
| Carrier, GO | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Physical Activity and Obesity: The Role of Nitric Oxide and Eicosanoids in Regulating Capillary Perfusion and Vascular Insulin Resistance[NCT02060240] | 30 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Insulin Sensitivity
| Article | Year |
|---|---|
Chronic treatment with epoxyeicosatrienoic acids modulates insulin signaling and prevents insulin resistance in hepatocytes.
Topics: 8,11,14-Eicosatrienoic Acid; Hep G2 Cells; Hepatocytes; Humans; Insulin; Insulin Receptor Substrate | 2011 |
Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Brachial Artery; Capillaries; Contrast Media; Glucose Toleranc | 2012 |
Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; In Vitro Techniques; Insulin Resistance; Male; Mesenteric Arte | 2001 |